Medical costs of Alpha-1 antitrypsin deficiency-associated COPD in the United States.

MLA

Sieluk, Jan, et al. “Medical Costs of Alpha-1 Antitrypsin Deficiency-Associated COPD in the United States.” Orphanet Journal of Rare Diseases, vol. 15, no. 1, Sept. 2020, p. 260. EBSCOhost, https://doi.org/10.1186/s13023-020-01523-4.

APA

Sieluk, J., Slejko, J. F., Silverman, H., Perfetto, E., & Mullins, C. D. (2020). Medical costs of Alpha-1 antitrypsin deficiency-associated COPD in the United States. Orphanet Journal of Rare Diseases, 15(1), 260. https://doi.org/10.1186/s13023-020-01523-4

Chicago

Sieluk, Jan, Julia F Slejko, Henry Silverman, Eleanor Perfetto, and C Daniel Mullins. 2020. “Medical Costs of Alpha-1 Antitrypsin Deficiency-Associated COPD in the United States.” Orphanet Journal of Rare Diseases 15 (1): 260. doi:10.1186/s13023-020-01523-4.